背景与目的:T细胞性非霍奇金淋巴瘤(T-cell non-Hodgkin's lymphoma,T-NHL)预后不良,有体外研究表明淋巴瘤细胞株的髓细胞白血病1(myeloid ..
基于4个网页-相关网页
...文奇,管忠震, 心期刊 ISSN : 1000-467X(2006)04-0486-04 背景与目的:复发或耐药的B细胞性非霍奇金淋巴瘤(non-Hodgkin's lymphoma,NHL)预后不良,二线方案化疗远期生存差;抗CD20单克隆抗体美罗华(rituximab)与CHOP或类似方..
基于4个网页-相关网页
结果:淋巴瘤标本共50例,免疫组织化学检查均为B细胞性非霍奇金淋巴瘤(B cell non Hodgkin lymphoma,B-NHL),其中36例为结外边缘区B细胞淋巴瘤,黏膜相关淋巴组织型(MZL-MALT),占72.0%;淋巴浆细...
基于2个网页-相关网页
...'s lymphoma，NHL)为目前增长速度最快的恶性肿瘤，与西方国家相比，T细胞性非霍奇金淋巴瘤(T-cell non-hodgkin'slymphoma,T-NHL)在中国、日本等亚洲人群中发病率较高，与B细胞性淋巴瘤(B-cell non-hodgkin's ly...
基于2个网页-相关网页
大细胞滤泡性非霍奇金淋巴瘤 Non-Hodgkin's lymphoma large cell, follicular
大细胞（弥漫性）非霍奇金淋巴瘤 Non-Hodgkin's lymphoma large cell (diffuse)
原淋巴细胞(弥漫性)非霍奇金淋巴瘤 Non-Hodgkin's lymphoma lymphoblastic (diffuse)
免疫母细胞(弥漫性)非霍奇金淋巴瘤 Non-Hodgkin's lymphoma immunoblastic (diffuse)
克隆性免疫球蛋白重链基因重排检测可以作为诊断恶性B细胞性非霍奇金淋巴瘤的有效分子标志。
Clonal immunoglobulin heavy chain gene rearrangement can be used as a effective diagnostic molecular marker for B-NHL.
Rituxan现在已经被批准用于非霍奇金淋巴瘤、慢性淋巴细胞白血病和风湿性关节炎的治疗。
Rituxan is currently approved as a treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.
滤泡性B细胞淋巴瘤是一种非霍奇金淋巴瘤，肿瘤疫苗是治疗是根据肿瘤细胞的生物学特殊性。
The cancer vaccines rely on a biological quirk of follicular B-cell lymphoma, which is a type of non-Hodgkin's lymphoma.
应用推荐